AU2002218280A1 - Process - Google Patents
ProcessInfo
- Publication number
- AU2002218280A1 AU2002218280A1 AU2002218280A AU1828002A AU2002218280A1 AU 2002218280 A1 AU2002218280 A1 AU 2002218280A1 AU 2002218280 A AU2002218280 A AU 2002218280A AU 1828002 A AU1828002 A AU 1828002A AU 2002218280 A1 AU2002218280 A1 AU 2002218280A1
- Authority
- AU
- Australia
- Prior art keywords
- core
- outer coating
- exterior
- openings
- active agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23B—TURNING; BORING
- B23B37/00—Boring by making use of ultrasonic energy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Abstract
An oral delivery device comprising a core which includes a pharmaceutically active agent, the core covered by an outer coating which includes one or more openings in the outer coating communicating from the exterior of the device toward the core, with a thin layer of the coating material over the core at the bottom of the opening.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0027471.2 | 2000-11-08 | ||
GBGB0027471.2A GB0027471D0 (en) | 2000-11-08 | 2000-11-08 | Processes |
PCT/EP2001/012729 WO2002038131A2 (en) | 2000-11-08 | 2001-11-02 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002218280A1 true AU2002218280A1 (en) | 2002-05-21 |
Family
ID=9902924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002218280A Abandoned AU2002218280A1 (en) | 2000-11-08 | 2001-11-02 | Process |
Country Status (9)
Country | Link |
---|---|
US (2) | US7923027B2 (en) |
EP (2) | EP1333813B1 (en) |
JP (1) | JP4290981B2 (en) |
AT (2) | ATE314839T1 (en) |
AU (1) | AU2002218280A1 (en) |
DE (2) | DE60116530T2 (en) |
ES (2) | ES2256329T3 (en) |
GB (1) | GB0027471D0 (en) |
WO (1) | WO2002038131A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
WO2003026628A2 (en) * | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
MY139719A (en) * | 2002-02-12 | 2009-10-30 | Glaxo Group Ltd | Oral dosage form for controlled drug release |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
CA2499955A1 (en) * | 2002-09-28 | 2004-04-08 | Mcneil-Ppc, Inc. | Delayed release dosage forms |
GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
US20050169994A1 (en) * | 2003-11-25 | 2005-08-04 | Burke Matthew D. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
US8067029B2 (en) * | 2004-01-13 | 2011-11-29 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US7404708B2 (en) * | 2004-12-07 | 2008-07-29 | Mcneil-Ppc, Inc. | System and process for providing at least one opening in dosage forms |
CA2635566A1 (en) * | 2005-12-30 | 2007-07-12 | Accu-Break Technologies, Inc. | Adhesively bonded dosage form |
US8273105B2 (en) | 2008-02-20 | 2012-09-25 | Tyco Healthcare Group Lp | Compound barb medical device and method |
CA2726259C (en) * | 2008-06-04 | 2014-07-29 | Colgate-Palmolive Company | Oral care implement with cavitation system |
WO2010009433A1 (en) * | 2008-07-18 | 2010-01-21 | Valeant Pharmaceuticals International | Modified release formulation and methods of use |
US20100323016A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
US20100323015A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
WO2020234716A1 (en) | 2019-05-17 | 2020-11-26 | Glaxosmithkline Intellectual Property Development Limited | Matrix composition comprising (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1575050A1 (en) * | 1966-01-12 | 1972-04-13 | Misto Gen Equipment Co | Ultrasonic fog generator |
US4447235A (en) * | 1981-05-07 | 1984-05-08 | John M. Clarke | Thoracentesis device |
US4693886A (en) * | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
EP0303769A3 (en) * | 1987-08-18 | 1989-10-25 | Balzers Aktiengesellschaft | Device for the transmission of rotary movements through a wall of a vacuum chamber |
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
JPH02124251A (en) | 1988-10-28 | 1990-05-11 | Tanaka Kikinzoku Kogyo Kk | Micro hole processing method |
US5123903A (en) * | 1989-08-10 | 1992-06-23 | Medical Products Development, Inc. | Disposable aspiration sleeve for ultrasonic lipectomy |
US5317932A (en) * | 1992-02-28 | 1994-06-07 | The Dow Chemical Company | Sample probe |
US5300046A (en) * | 1992-03-30 | 1994-04-05 | Symbiosis Corporation | Thoracentesis sheath catheter assembly |
US5674235A (en) * | 1995-05-10 | 1997-10-07 | Ultralase Technologies International | Ultrasonic surgical cutting instrument |
JPH1024491A (en) | 1996-07-11 | 1998-01-27 | Seidensha Denshi Kogyo Kk | Ultrasonic machining apparatus |
US6783662B2 (en) * | 1999-03-18 | 2004-08-31 | Exxonmobil Research And Engineering Company | Cavitation enhanced liquid atomization |
AU776314B2 (en) * | 1999-07-20 | 2004-09-02 | Merck & Co., Inc. | Sustained release drug dispersion delivery device |
EP1227800A1 (en) * | 1999-10-29 | 2002-08-07 | Merck & Co., Inc. | Osmotic controlled release drug delivery device |
US7708504B2 (en) * | 2005-08-29 | 2010-05-04 | Savannah River Nuclear Solutions, Llc | Pneumatic conveyance apparatus and process |
-
2000
- 2000-11-08 GB GBGB0027471.2A patent/GB0027471D0/en not_active Ceased
-
2001
- 2001-11-02 JP JP2002540721A patent/JP4290981B2/en not_active Expired - Fee Related
- 2001-11-02 US US10/416,116 patent/US7923027B2/en not_active Expired - Fee Related
- 2001-11-02 ES ES01993458T patent/ES2256329T3/en not_active Expired - Lifetime
- 2001-11-02 DE DE60116530T patent/DE60116530T2/en not_active Expired - Lifetime
- 2001-11-02 AU AU2002218280A patent/AU2002218280A1/en not_active Abandoned
- 2001-11-02 WO PCT/EP2001/012729 patent/WO2002038131A2/en active IP Right Grant
- 2001-11-02 DE DE60138428T patent/DE60138428D1/en not_active Expired - Lifetime
- 2001-11-02 ES ES05077703T patent/ES2323879T3/en not_active Expired - Lifetime
- 2001-11-02 AT AT01993458T patent/ATE314839T1/en not_active IP Right Cessation
- 2001-11-02 EP EP01993458A patent/EP1333813B1/en not_active Expired - Lifetime
- 2001-11-02 AT AT05077703T patent/ATE428407T1/en not_active IP Right Cessation
- 2001-11-02 EP EP05077703A patent/EP1655024B1/en not_active Expired - Lifetime
-
2011
- 2011-02-17 US US13/029,198 patent/US8765065B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1655024B1 (en) | 2009-04-15 |
WO2002038131A3 (en) | 2002-09-12 |
EP1333813B1 (en) | 2006-01-04 |
DE60116530T2 (en) | 2006-08-10 |
US8765065B2 (en) | 2014-07-01 |
EP1655024A1 (en) | 2006-05-10 |
ATE314839T1 (en) | 2006-02-15 |
ES2323879T3 (en) | 2009-07-27 |
US20040062806A1 (en) | 2004-04-01 |
US7923027B2 (en) | 2011-04-12 |
WO2002038131A2 (en) | 2002-05-16 |
JP4290981B2 (en) | 2009-07-08 |
GB0027471D0 (en) | 2000-12-27 |
EP1333813A2 (en) | 2003-08-13 |
DE60116530D1 (en) | 2006-03-30 |
US20110131754A1 (en) | 2011-06-09 |
ATE428407T1 (en) | 2009-05-15 |
ES2256329T3 (en) | 2006-07-16 |
DE60138428D1 (en) | 2009-05-28 |
JP2004512903A (en) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002218280A1 (en) | Process | |
USD494065S1 (en) | Spray dispenser cap | |
CA2417511A1 (en) | Dispensing device for dispensing scents | |
USD449002S1 (en) | Bottle | |
PL360473A1 (en) | Hydrophilic coating including dlc on substrate | |
IL166561A0 (en) | Pharmaceutical compositions | |
ATE404179T1 (en) | DOSAGE FORMS WITH CORE AND OUTER SHELL | |
CA2432203A1 (en) | Sustained release drug delivery devices with multiple agents | |
CA2433032A1 (en) | Sustained release drug delivery devices with coated drug cores | |
PT1405621E (en) | Method of manufacturing tablet | |
AU2002350246A1 (en) | Providing content delivery during a call hold condition | |
WO2002072033A3 (en) | Chronotherapeutic dosage forms containing glucocorticosteroid | |
AU5820400A (en) | Macrolides | |
AU2715701A (en) | Wire, tube or catheter with hydrophilic coating | |
WO2004041918A3 (en) | Microstructures and methods of fabrication thereof | |
CA2432290A1 (en) | Absorbent article | |
AU2367001A (en) | Device for storing and dispensing a free-flowing substance | |
AU2001263083A1 (en) | Biologically active 4h-benzo(1,4)oxazin-3-ones | |
AU2001258442A1 (en) | Drug delivery device, especially for the delivery of levonorgestrel | |
MXPA02004860A (en) | 3-(4, 5-dihydroisoxazole -5-yl) benzoylpyrazole. | |
USD434784S (en) | Portion of a sidewall of a nozzle for dispensing adhesives and sealants | |
USD470531S1 (en) | Transfer tape dispenser | |
MXPA03007272A (en) | Medicament formulation containing a muscarinic agonist. | |
AU7687300A (en) | Reference wafer for controlling accuracy and method for producing the same, aligner, and method for fabricating device | |
AU6481700A (en) | Spinning nozzle, spinning nipple incorporating the spinning nozzle therein, and method for manufacturing both the same |